ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 111,63
0,11%
Dow Jones
43 840,91
1,39%
DAX
22 551,43
0,12%
Brent Oil
73,045
0,00%
Bitcoin
85 052,25
0,82%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Cyclacel Pharmaceuticals Inc (CYCC) Cours

Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals Inc (CYCC)

NASDAQ
0,3315
-0,0374
(-10,14%)
Fermé 01 Mars 10:00PM
Retardé de 15 minutes
0,3299
-0,0016
(-0,48%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,3299
Prix Achat
0,3171
Prix Vente
0,3364
Volume échangé
715 684
0,322 Fourchette du Jour 0,3488
0,3014 Plage de 52 semaines 4,00
Cap du marché
2,074M
Clôture Veille
0,3689
Ouverture
0,341
Dernière Transaction
650
@
0.3299
(formt)
Dernière heure de transaction
Volume financier
US$ 241 689
VWAP
0,337704
Volume moyen (3 m)
2 618 852
Actions en circulation
6 287 205
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,09
Bénéfice par action (BPA)
-3,62
Chiffre d'affairess
420k
Bénéfice net
-22,76M

À propos de Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitor... Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.cyclacel.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Cyclacel Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker CYCC. Le dernier cours de clôture d'Cyclacel Pharmaceuticals était de US$0,37. Au cours de la dernière année, les actions de Cyclacel Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,3014 à US$ 4,00.

Cyclacel Pharmaceuticals compte actuellement 6 287 205 actions en circulation. La capitalisation boursière d'Cyclacel Pharmaceuticals est de US$2,32 million. Cyclacel Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.09.

CYCC Dernières nouvelles

Plus de nouvelles
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0192-5.499856774560.34910.3950.3106016277310.36248809CS
4-0.0102-2.99911790650.34010.3950.30144512470.34828694CS
12-0.0576-14.8645161290.38750.890.301426188520.44351741CS
26-0.8301-71.56034482761.162.490.301419042080.65101225CS
52-2.3801-87.82656826572.7140.301411860630.9626076CS
156-48.7201-99.32742099949.0555.050.30145681406.13216068CS
260-155.6701-99.788525641156288.750.301447948431.78576302CS

CYCC - Frequently Asked Questions (FAQ)

What is the current Cyclacel Pharmaceuticals share price?
The current share price of Cyclacel Pharmaceuticals is US$ 0,3299
How many Cyclacel Pharmaceuticals shares are in issue?
Cyclacel Pharmaceuticals has 6 287 205 shares in issue
What is the market cap of Cyclacel Pharmaceuticals?
The market capitalisation of Cyclacel Pharmaceuticals is USD 2,32M
What is the 1 year trading range for Cyclacel Pharmaceuticals share price?
Cyclacel Pharmaceuticals has traded in the range of US$ 0,3014 to US$ 4,00 during the past year
What is the PE ratio of Cyclacel Pharmaceuticals?
The price to earnings ratio of Cyclacel Pharmaceuticals is -0,09
What is the cash to sales ratio of Cyclacel Pharmaceuticals?
The cash to sales ratio of Cyclacel Pharmaceuticals is 4,79
What is the reporting currency for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Cyclacel Pharmaceuticals?
The latest annual turnover of Cyclacel Pharmaceuticals is USD 420k
What is the latest annual profit for Cyclacel Pharmaceuticals?
The latest annual profit of Cyclacel Pharmaceuticals is USD -22,76M
What is the registered address of Cyclacel Pharmaceuticals?
The registered address for Cyclacel Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cyclacel Pharmaceuticals website address?
The website address for Cyclacel Pharmaceuticals is www.cyclacel.com
Which industry sector does Cyclacel Pharmaceuticals operate in?
Cyclacel Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STAKSTAK Inc
US$ 3,97
(156,13%)
174,23k
ORGOOrganogenesis Holdings Inc
US$ 6,21
(102,28%)
59M
TRNRInteractive Strength Inc
US$ 2,57
(67,97%)
193,57M
PMAXPowell Max Ltd
US$ 0,511
(43,54%)
137,18M
ARBBARB IOT Group Ltd
US$ 0,6635
(38,23%)
59,08M
NVNINVNI Group Ltd
US$ 0,99
(-50,50%)
72,79M
SPGCSacks Parente Golf Inc
US$ 0,2085
(-48,65%)
58,21M
ADGMAdagio Medical Holdings Inc
US$ 0,8081
(-47,53%)
756,76k
PRAXPraxis Precision Medicines Inc
US$ 38,60
(-40,64%)
3,2M
SAGSAG Holdings Ltd
US$ 1,19
(-38,97%)
789,86k
NVDANVIDIA Corporation
US$ 124,92
(3,97%)
389,48M
TRNRInteractive Strength Inc
US$ 2,57
(67,97%)
193,57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13,44
(7,78%)
154,46M
PMAXPowell Max Ltd
US$ 0,511
(43,54%)
137,18M
LCIDLucid Group Inc
US$ 2,22
(-0,45%)
136,17M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CYCC
Cyclacel Pharmaceuticals
LSE
0LXN
Pozbud T&r
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces